NCT00362856View on ClinicalTrials.gov

Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 13, 2006

Primary Completion Date

March 6, 2007

Study Completion Date

March 6, 2007

Conditions
Celiac Disease
Interventions
DRUG

larazotide acetate

capsule

DRUG

Placebo

capsule

Trial Locations (9)

15241

Pittsburgh

19107

Research Site, Philadelphia

23298

Research Site, Richmond

55905

Research Site, Rochester

58501

Bismarck

85259

Research Site, Scottsdale

92123

San Diego

02215

Research Site, Boston

07960

Morristown

Sponsors
All Listed Sponsors
lead

9 Meters Biopharma, Inc.

INDUSTRY

NCT00362856 - Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects | Biotech Hunter | Biotech Hunter